3 changes coming to drug pricing
No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the changing drug-pricing landscape
Chance Scott
Chance Scott is a partner specializing in life sciences for Guidehouse based in Austin, Texas. He is the practice lead for Guidehouse's Market Access Center of Excellence for the pharmaceutical segment. Prior to Guidehouse, he spearheaded a number of launch readiness engagements while at Campbell Alliance Consulting Group. Additionally, he held several roles in the commercial organization at Genentech, including sales training and oncology field sales.